XTalks

DECEMBER 28, 2023

This results in anemia, characterized by a decreased number of RBCs, and jaundice, indicated by high bilirubin levels, typically appearing within the first days or weeks of life. “The ability to detect fetal antigens as early as ten weeks is only made possible due to our expertise in fetal DNA quantification.

Trials 97

Trials Clinical Trials Clinical Trials Antibody 97

XTalks

MAY 12, 2022

The life of the transplant recipient crucially depends on the early detection of any signs of organ or graft rejection. This diagnostic assay works on the principle of in vitro nucleic acid amplification using real-time transcription-mediated amplification (TMA) technology. Cytomegalovirus (CMV) Infection in Transplant Recipients.

In-Vitro 52

In-Vitro DNA Development Genome 52

The Pharma Data

DECEMBER 22, 2020

Available since 2017 as an in vitro diagnostic assay (IVD) in Europe and the United States, Japanese clinical geneticists can now have access to this assay to help identify a definitive genetic diagnosis for their patients. SANTA CLARA, Calif.–( –( BUSINESS WIRE )– Agilent Technologies Inc.

Genome 40

Genome Genomics Genetics In-Vitro 40

Drug Discovery World

FEBRUARY 27, 2023

“We’re transforming drug discovery, and it all begins in the lab where researchers can leverage multimode plate reader technology like the EnVision Nexus system to increase R&D productivity at nearly every stage of their process,” said PerkinElmer Senior Vice President of Life Sciences Alan Fletcher. “By

Drugs 52

Drugs Life Science Protein Scientist 52

XTalks

NOVEMBER 7, 2022

Liquid biopsy tests in oncology involve isolating entities such as circulating tumor cells (CTC), circulating tumor DNA (ctDNA) and tumor-derived exosomes. These tumor-derived entities are used to derive genomic and proteomic data. The same webinar held a Q&A session with Dr. Bahassi and two other experts from Medpace, Dr. Lyon L.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

XTalks

SEPTEMBER 30, 2020

The two studies were recently published online in the journal Science, both of which were led by Jean-Laurent Casanova, an infectious disease geneticist at Rockefeller University. The team sequenced DNA from 659 critically ill COVID-19 patients and 534 controls with mild or asymptomatic disease. Mutational Errors in COVID-19 Patients.

Antibody 135

Antibody Genetics Research In-Vitro 135

XTalks

AUGUST 12, 2020

Despite the effectiveness of anti-retroviral therapy (ART) in significantly improving health, quality of life and reducing mortality among HIV-positive individuals, new research shows that persistent infections may be due to the ability of the virus to take refuge in distinct subsets of immune T cells.

RNA 52

RNA Protein DNA In-Vivo 52